Adiponectin improves hepatic insulin resistance by reducing glycogenesis and lipogenesis and increasing glucose utilization [29] and also improves vascular function by stimulating endothelial NO production and antiatherogenic effects by inhibiting inflammation in vascular systems [30]. The gene discussed is ADIPOQ; the disease is Insulin resistance.